Published in Phys Med Biol on January 25, 2007
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys (2010) 2.32
Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol (2010) 1.20
Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy. Br J Radiol (2010) 0.88
The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy. Phys Med Biol (2011) 2.36
Potent amyloidogenicity and pathogenicity of Aβ43. Nat Neurosci (2011) 1.76
FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck (2002) 1.66
[Health personnel's dress-code must combine confidence and good hygiene]. Lakartidningen (2007) 1.39
Stricture of the proximal esophagus in head and neck carcinoma patients after radiotherapy. Cancer (2003) 1.28
Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol (2007) 1.18
A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr (2011) 1.17
Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol (2011) 1.15
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier. Lab Invest (2003) 1.10
Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med (2009) 1.10
Nuclear deadenylation/polyadenylation factors regulate 3' processing in response to DNA damage. EMBO J (2010) 1.08
The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives. Cancer Imaging (2014) 1.03
A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes. Acta Oncol (2012) 1.03
Inhibition of mRNA deadenylation by the nuclear cap binding complex (CBC). J Biol Chem (2005) 1.00
Structural basis of m(7)GpppG binding to poly(A)-specific ribonuclease. Structure (2009) 1.00
In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line. Acta Oncol (2005) 0.99
Brain inflammation induces post-synaptic changes during early synapse formation in adult-born hippocampal neurons. Exp Neurol (2013) 0.98
Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib. Acta Oncol (2009) 0.95
A systematic overview of radiation therapy effects in non-small cell lung cancer. Acta Oncol (2003) 0.95
Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines. J Cancer Res Clin Oncol (2008) 0.95
Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone. Acta Oncol (2004) 0.94
Impact of beam quality on megavoltage radiotherapy treatment techniques utilizing gold nanoparticles for dose enhancement. Phys Med Biol (2013) 0.93
Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures. Phys Med Biol (2007) 0.93
4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U/S-based prostate HDR brachytherapy treatment delivery. Med Phys (2011) 0.92
Dose-response relations for anal sphincter regarding fecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Radiobiological study of 65 consecutive patients. Strahlenther Onkol (2005) 0.91
Life years lost--comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale. Cancer (2012) 0.91
Weight and body mass index in relation to irradiated volume and to overall survival in patients with oropharyngeal cancer: a retrospective cohort study. Radiat Oncol (2014) 0.90
Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int J Radiat Oncol Biol Phys (2005) 0.90
Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy. Acta Oncol (2003) 0.90
Three-dimensional atlas of lymph node topography based on the visible human data set. Anat Rec B New Anat (2006) 0.90
Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma--the ARTSCAN study. Radiother Oncol (2011) 0.88
Reply to the comment on 'The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy'. Phys Med Biol (2013) 0.88
Reduction of radiation doses to patients and staff during endoscopic retrograde cholangiopancreatography. Saudi J Gastroenterol (2011) 0.87
What's new in target volume definition for radiologists in ICRU Report 71? How can the ICRU volume definitions be integrated in clinical practice? Cancer Imaging (2007) 0.86
Radiation-induced trismus in the ARTSCAN head and neck trial. Acta Oncol (2014) 0.86
Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro. Cancer Biother Radiopharm (2009) 0.86
The impact of different dose-response parameters on biologically optimized IMRT in breast cancer. Phys Med Biol (2008) 0.86
Poly(A)-specific ribonuclease (PARN): an allosterically regulated, processive and mRNA cap-interacting deadenylase. Crit Rev Biochem Mol Biol (2013) 0.86
Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines. J Cancer Res Clin Oncol (2011) 0.86
Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy. Acta Oncol (2012) 0.85
Recognition of adenosine residues by the active site of poly(A)-specific ribonuclease. J Biol Chem (2009) 0.85
Comments on 'Reconsidering the definition of a dose-volume histogram'--dose-mass histogram (DMH) versus dose-volume histogram (DVH) for predicting radiation-induced pneumonitis. Phys Med Biol (2006) 0.85
Altered synaptic properties during integration of adult-born hippocampal neurons following a seizure insult. PLoS One (2012) 0.85
Evaluation of the effect of prostate volume change on tumor control probability in LDR brachytherapy. J Contemp Brachytherapy (2011) 0.84
Effects of positioning uncertainty and breathing on dose delivery and radiation pneumonitis prediction in breast cancer. Acta Oncol (2002) 0.84
A radionuclide dosimetry toolkit based on material-specific Monte Carlo dose kernels. Nucl Med Commun (2009) 0.84
Particle therapy - a next logical step in the improvement of radiotherapy. Acta Oncol (2011) 0.84
Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. Med Oncol (2012) 0.84
Complement C3 and C5 deficiency affects fracture healing. PLoS One (2013) 0.84
Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays. In Vitro Cell Dev Biol Anim (2007) 0.84
The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay. Radiat Oncol (2009) 0.84
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men. Osteoporos Int (2005) 0.83
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L Study. Eur J Cancer (2008) 0.83
A radiobiological analysis of the effect of 3D versus 4D image-based planning in lung cancer radiotherapy. Phys Med Biol (2009) 0.83
Relation between smoking history and gene expression profiles in lung adenocarcinomas. BMC Med Genomics (2012) 0.83
Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer. Int J Gynecol Cancer (2009) 0.83
Human prefoldin inhibits amyloid-β (Aβ) fibrillation and contributes to formation of nontoxic Aβ aggregates. Biochemistry (2013) 0.83
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck. J Exp Clin Cancer Res (2009) 0.83
An inhomogeneity correction algorithm for irregular fields of high-energy photon beams based on Clarkson integration and the 3D beam subtraction method. J Appl Clin Med Phys (2006) 0.83
Patient specific pre-treatment QA verification using an EPID approach. Technol Cancer Res Treat (2013) 0.83
Radiobiological evaluation of forward and inverse IMRT using different fractionations for head and neck tumours. Radiat Oncol (2010) 0.82
Medical imaging for improved tumour characterization, delineation and treatment verification. Acta Oncol (2002) 0.82
Analysis of the penumbra enlargement in lung versus the quality index of photon beams: a methodology to check the dose calculation algorithm. Med Phys (2004) 0.82
FDG-PET in cervical cancer: staging, re-staging and follow-up. Acta Obstet Gynecol Scand (2007) 0.82
Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer. Eur J Cancer (2011) 0.82
Esophageal stricture after radiotherapy in patients with head and neck cancer: experience of a single institution over 2 treatment periods. Head Neck (2010) 0.81
Elimination of motion and pulsation artifacts using BLADE sequences in knee MR imaging. Magn Reson Imaging (2012) 0.81
Comparison of the helical tomotherapy and MLC-based IMRT radiation modalities in treating brain and cranio-spinal tumors. Technol Cancer Res Treat (2009) 0.81
Variation in radiation sensitivity and repair kinetics in different parts of the spinal cord. Acta Oncol (2008) 0.81
Dosimetric and radiobiological evaluation of dose distribution perturbation due to head heterogeneities for Linac and Gamma Knife stereotactic radiotherapy. Acta Oncol (2008) 0.81
Comparison of two radiotherapeutic hypofractionated schedules in the application of tumor bed boost. Clin Breast Cancer (2013) 0.81
On the biologically effective dose (BED)-using convolution for calculating the effects of repair: II. Numerical considerations. Phys Med Biol (2013) 0.81
Ribosomal protein S19 binds to its own mRNA with reduced affinity in Diamond-Blackfan anemia. Blood Cells Mol Dis (2010) 0.80
Prognostic significance of intratumour microvessel density and haemoglobin level in carcinoma of the uterine cervix. Acta Oncol (2002) 0.80
Radiotherapy response in head and neck cancer - evaluation of the primary tumour site. Acta Otolaryngol (2014) 0.80
Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). Eur J Cancer (2009) 0.80
The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRT. Radiother Oncol (2008) 0.80
Characterization of a novel 2D array dosimeter for patient-specific quality assurance with volumetric arc therapy. Med Phys (2013) 0.80
Influence of initial electron beam characteristics on monte carlo calculated absorbed dose distributions for linear accelerator electron beams. Phys Med Biol (2002) 0.80
Elimination of motion, pulsatile flow and cross-talk artifacts using blade sequences in lumbar spine MR imaging. Magn Reson Imaging (2013) 0.79
Conversion of helical tomotherapy plans to step-and-shoot IMRT plans--Pareto front evaluation of plans from a new treatment planning system. Med Phys (2011) 0.79
Investigation of the dose- and time-dependence of the induction of different types of cell death in a small‑cell lung cancer cell line: Implementation of the repairable-conditionally repairable model. Int J Oncol (2013) 0.79